Subscribe

Recent Posts

• FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA

  Feb 6, 2026 | Injectibles
• HHS Leaders Back Plastic Surgeons’ Opposition to Gender-Related Surgery for Minors

  Feb 4, 2026 | Industry News
• Recent Antibiotic Use Raises Infection Risk in Tissue Expander–Based Breast Reconstruction

  Feb 4, 2026 | Reconstructive Surgery
• Survey Reveals Knowledge Gap on Menopause-Related Skin Changes

  Feb 4, 2026 | Aesthetics
• What Recent Studies Reveal About Natural Results With OnabotulinumtoxinA

  Feb 3, 2026 | Botox